CELU Stock Analysis: Buy, Sell, or Hold?
CELU - Celularity Inc. Class A Common Stock
$0.88
-0.03 (-3.04%)
▼
5d:
-8.06%
30d:
-35.3%
90d:
-32.32%
HOLD
LOW Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 08, 2026
0d
Get Alerted When CELU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CELU shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CELU shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CELU is currently trading at $0.88, which is considered oversold relative to its 30-day fair value range of $1.00 to $1.33.
Technical Outlook: Technically, CELU is in a downtrend. The price is currently testing key support at $0.87. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.50 (+184.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CELU is in a downtrend. The price is currently testing key support at $0.87. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.50 (+184.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.00 -
$1.33
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding CELU? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.0%)
- BULLISH: Trading 184.1% below Wall St target ($2.50)
- CAUTION: Recommendation downgraded due to -8.1% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.00 -
$1.33
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.87
Resistance Level
$1.15
Current Trend
Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Wall Street Target
$2.50
(+184.1%)
Revenue Growth (YoY)
-77.4%
Earnings Growth (YoY)
-61.3%
Share & Embed Analysis
Last updated: May 08, 2026 7:52 PM ET
Data refreshes hourly during market hours. Next update: 8:52 PM
Data refreshes hourly during market hours. Next update: 8:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CELU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 60 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 54 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 60 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 52 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 57 HOLD |
Advanced CELU Option Strategies
Professional options setups generated by AI based on today's CELU price and gamma walls.
